About NightWatch
NightWatch is a company based in Leiden (Netherlands) founded in 2013 by Mark Bloemendaal, Asmund Tielen, and Asmund Tielens. NightWatch offers products and services including NightWatch Device. NightWatch operates in a competitive market with competitors including Empatica, NeuroPace, Seer, Cadence Neuroscience and Epitel, among others.
- Headquarter Leiden, Netherlands
- Founders Mark Bloemendaal, Asmund Tielen, Asmund Tielens
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Livassured B.V.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$55.29 K (USD), Grant
Mar 31, 2020
-
Investors
European Union
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NightWatch
NightWatch offers a comprehensive portfolio of products and services, including NightWatch Device.
Wearable system for detecting and alerting epileptic seizures during sleep.
Funding Insights of NightWatch
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $55,285
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Grant - NightWatch | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - NightWatch | Valuation |
investors |
|
| Sep, 2018 | Amount | Series A - NightWatch | Valuation | Oost NL , Health Innovations |
|
Investors in NightWatch
NightWatch has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Oost NL and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Sector-agnostic VC firm investing in geographies such as the Netherlands
|
Founded Year | Domain | Location | |
|
Health Innovations is focused on investing in healthcare improvements.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NightWatch
Financial Statements - NightWatch
Nightwatch Comparisons
Competitors of NightWatch
NightWatch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Empatica, NeuroPace, Seer, Cadence Neuroscience and Epitel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a wrist band to monitor physiological signals
|
|
| domain | founded_year | HQ Location |
Implantable neurostimulation systems for epilepsy treatment are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Medical devices for treating neurological disorders like epilepsy are developed.
|
|
| domain | founded_year | HQ Location |
Wearable EEG system for epilepsy monitoring and control is provided.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for epilepsy patients
|
Latest news on Nightwatch
Frequently Asked Questions about NightWatch
NightWatch was founded in 2013 and raised its 1st funding round 5 years after it was founded.
NightWatch is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Jeroen Van Den Hout is the current CEO of NightWatch.
NightWatch was founded in 2013 in Leiden, Netherlands, within the health technology sector. Wearable armbands are developed to monitor heart rate and motion during sleep, enabling detection of tonic and tonic-clonic epileptic seizures. Wireless alerts are transmitted to a base station to notify caregivers of potential risks. The focus remains on supporting epilepsy management through this non-invasive device for overnight use.
NightWatch offers NightWatch Device.
NightWatch has 5 investors. Key investors include European Union, Oost NL, EIC Fund, Health Innovations, and Holland Capital.